Correction: Efficacy and safety of tirzepatide for weight loss in patients with obesity or type 2 diabetes: a systematic review and meta-analysis

Correction: Efficacy and safety of tirzepatide for weight loss in patients with obesity or type 2 diabetes: a systematic review and meta-analysis

Saved in:

Bibliographic Details
Main Authors:	Qiru Tian, Yi Song, Yan Deng, Shike Lin
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-08-01
Series:	Frontiers in Endocrinology
Subjects:	tirzepatide weight loss meta-analysis obesity type 2 diabetes adverse events
Online Access:	https://www.frontiersin.org/articles/10.3389/fendo.2025.1683829/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Efficacy and safety of tirzepatide for weight loss in patients with obesity or type 2 diabetes: a systematic review and meta-analysis
by: Qiru Tian, et al.
Published: (2025-07-01)

Effect of tirzepatide-induced weight loss on adipose tissue in obesity: rationale and design of the randomized placebo-controlled Tirzepatide Brown and Beige Adipose Tissue Activation (TABFAT) trial
by: Rok Herman, et al.
Published: (2025-08-01)

Tirzepatide – a new hope for type 2 diabetes mellitus and obesity management. A literature review.
by: Izabela Stawicka, et al.
Published: (2024-11-01)

Tirzepatide safety in type 2 diabetes: a disproportionality analysis of adverse events using the FDA FAERS database
by: Zhenpo Zhang, et al.
Published: (2025-07-01)

Efficacy and Safety of Tirzepatide in the Treatment of Obesity in Adults: A Comprehensive Review
by: Karolina Skonieczna, et al.
Published: (2025-05-01)

Case Report: Rhabdomyolysis following initiation of tirzepatide
by: Jonas Michael Bodanowitz, et al.
Published: (2025-08-01)

Weight Loss and Engagement in a Tirzepatide-Supported Digital Obesity Program: A Four-Arm Patient-Blinded Retrospective Cohort Study
by: Louis Talay, et al.
Published: (2024-04-01)

Impact of Anti‐obesity Medication Initiation and Duration on Weight Loss
by: M. Rami Bailony, et al.
Published: (2025-04-01)

Lifestyle and Atrial Fibrillation: The Role of Obesity, Exercise, and Weight Loss in Risk Reduction and Rhythm Management
by: Szymon Pucyło, et al.
Published: (2025-06-01)

Metabolic Scarring: The Persistent Impact of Past Obesity on Long‐Term Metabolic Health Despite Weight Loss
by: Ali Hemade, et al.
Published: (2025-07-01)

Weight Loss and the Older Adult: Risks and Benefits
by: Wendy Gans, et al.
Published: (2020-09-01)

Weight Loss and the Older Adult: Risks and Benefits
by: Wendy Gans, et al.
Published: (2020-09-01)

Weight Loss as Therapeutic Option to Restore Fertility in Obese Men: A Meta-Analytic Study
by: Daniele Santi, et al.
Published: (2025-04-01)

Rhabdomyolysis associated with the use of tirzepatide
by: Kunal Sonavane, et al.
Published: (2025-04-01)

Examining preferences for weight loss interventions among black men and women with overweight or obesity: A qualitative study
by: Snehaa Ray, et al.
Published: (2025-08-01)

Short-term impact of tirzepatide on metabolic hypogonadism and body composition in patients with obesity: a controlled pilot study
by: Sandro La Vignera, et al.
Published: (2025-07-01)

A comparison of Glucagon-like peptide-1 receptor agonists on weight change, side effects, and quality of life in Kuwait
by: Saleh Alali, et al.
Published: (2025-05-01)

The Novel Dual GIP and GLP‐1 Receptor Agonist Tirzepatide Attenuates Colon Cancer Development by Regulating Glucose Metabolism
by: Yikai Zhang, et al.
Published: (2025-05-01)

The Impact of Green Tea Consumption and Its Extracts on Fat Reduction and Weight Loss
by: Anita Ptak, et al.
Published: (2024-11-01)

Current and Emerging Parenteral and Peroral Medications for Weight Loss: A Narrative Review
by: Abdullah Al Lawati, et al.
Published: (2025-04-01)

Weight loss mediates improvement in proinsulin processing during GLP-1 receptor agonist treatment
by: Renjiao Liu, et al.
Published: (2025-07-01)

Efficacy and safety of GLP-1 receptor agonists on weight management and metabolic parameters in PCOS women: a meta-analysis of randomized controlled trials
by: Shike Lin, et al.
Published: (2025-05-01)

The Risk of Vestibular Disorders with Semaglutide and Tirzepatide: Findings from a Large Real-World Cohort
by: Eman A. Toraih, et al.
Published: (2025-04-01)

Weight gain or loss after diagnosis and survival outcomes in prostate cancer: a meta-analysis
by: Feilun Cui, et al.
Published: (2025-08-01)

VERY LOW CALORIE DIETS AFFECT LONG TERM WEIGHT LOSS AND HEALTH OUTCOMES: A SYSTEMATIC REVIEW
by: Sheila Amara Putri, et al.
Published: (2025-03-01)

Efficacy of Tirzepatide Dual GIP/GLP‐1 Receptor Agonist in Patients With Idiopathic Intracranial Hypertension. A Real‐World Propensity Score‐Matched Study
by: Ahmed Y. Azzam, et al.
Published: (2025-03-01)

Tirzepatide: A dual action approach to weight reduction and glycemic control in type 2 diabetes mellitus
by: Princy Domnic Dsouza, et al.
Published: (2025-01-01)

The effect of probiotics on weight management in patients with severe obesity undergoing metabolic and bariatric surgery: a systematic review and meta-analysis
by: Shi Wang, et al.
Published: (2025-12-01)

Impact of body loss weight-oriented psychotherapy on indices of depression and anxiety in group of patients with overweight and obesity
by: P. P. Balashov, et al.
Published: (2010-06-01)

PREGNANCY MONITORING IN PATIENTS WITH EXCESS WEIGHT OR OBESITY
by: E. L. Borovkova
Published: (2016-08-01)

Children’s birth weight and the risk of general obesity and central obesity in primary school children: a 4-year longitudinal study
by: Yi Lin, et al.
Published: (2025-03-01)

NEPHROPROTECTIVE EFFECTS OF LISINOPRIL IN THE THERAPY OF HYPERTENSIVE PATIENTS WITH OBESITY
by: S. G. Shulkina, et al.
Published: (2018-05-01)

From Diabetes to Weight Loss: The Problems with Semaglutide's Expanded Use
by: Rawan Othman
Published: (2025-08-01)

Potential of nutrition in body weight improvement in type 2 diabetes
by: S. O. Eliashevich, et al.
Published: (2023-07-01)

IS THE AMOUNT OF WEIGHT LOSS AFTER BARIATRIC SURGERY A FACTOR DETERMINING CARDIOMETABOLIC RISK REDUCTION?
by: Bedia Fulya Çalıkoğlu, et al.
Published: (2022-10-01)

Safety profile and dose-dependent adverse events of upadacitinib in randomized clinical trials: a systematic review and meta-analysis
by: Cong Zhang, et al.
Published: (2025-06-01)

A systematic review and Bayesian network meta-analysis for comparative safety assessment of favipiravir interventions in hospitalized COVID-19 patients
by: Kai Yang, et al.
Published: (2022-09-01)

Validation of the Brazilian version of the processes of change questionnaire in weight management in adults with overweight and obesity in Brazil
by: Quênia de Carvalho, et al.
Published: (2025-07-01)

Effect of hypoglycemic agents with weight loss effect plus a high protein diet and moderate exercise on diabetes remission in adults with obesity and type 2 diabetes: a randomized controlled trial
by: Shi Zhang, et al.
Published: (2025-05-01)

Efficacy and safety of Nivolumab in advanced gastric and gastroesophageal junction cancer: a meta-analysis of randomized controlled trials
by: Xinming Lei, et al.
Published: (2024-11-01)